Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

Archives of Dermatology
V P WerthDavid Jacobus

Abstract

To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV). A randomized, double-blind, placebo-controlled study with a crossover arm for those who failed treatment. A US multicenter outpatient study. Patients A total of 19 subjects enrolled among 5 centers, 9 randomized to receive dapsone and 10 to receive placebo. Inclusion criteria were biopsy and direct immunofluorescence-proven PV controlled with glucocorticoids and/or cytotoxic agents, disease in maintenance phase, and aged 18 to 80 years. Physicians had tried at least 2 tapers of glucocorticoids unsuccessfully and had 30 days of stable steroid dosage. Treatment for any patient unable to taper glucocorticoids by more than 25% within 4 months was declared a failure, and the patient was allowed to switch to the opposite medication while maintaining the double-blind. Main Outcome Measure The ability of patients to taper to 7.5 mg/d or less within 1 year of reaching the maximum dosage of the study drug. Of the 9 patients receiving dapsone, 5 were successfully treated, 3 failed treatment, and 1 dropped out of the study. Of the 10 patients receiving placebo, 3 were successfully treated, and 7 failed treatment. This primar...Continue Reading

Citations

Nov 7, 2007·Archives of Dermatological Research·Elizabeth Gaines, Victoria P Werth
Oct 15, 2009·American Journal of Clinical Dermatology·Hakan M Gürcan, A Razzaque Ahmed
Mar 17, 2010·Indian Journal of Dermatology, Venereology and Leprology·Amrinder J Kanwar, Dipankar De
Nov 19, 2014·American Journal of Clinical Dermatology·Lihi AtzmonyDaniel Mimouni
Jun 12, 2013·La Revue de médecine interne·S Duvert-Lehembre, P Joly
May 9, 2012·Immunology and Allergy Clinics of North America·Evan W Piette, Victoria P Werth
Dec 6, 2011·Clinics in Dermatology·Michael KasperkiewiczDetlef Zillikens
Sep 20, 2011·Dermatologic Clinics·Evan W Piette, Victoria P Werth
Mar 15, 2011·Annales de dermatologie et de vénéréologie·P Joly, C Sin
Sep 8, 2010·La Presse médicale·Hélène Lapeyre-Liénard, Pascal Joly
Apr 18, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Silke C HofmannLeena Bruckner-Tuderman
Aug 13, 2011·The Australasian Journal of Dermatology·Svetlana PopadicMilos Nikolic
Jul 6, 2010·Dermatologic Therapy·Richelle M KnudsonAlison J Bruce
Jun 10, 2014·The Journal of Dermatology·Masayuki AmagaiYasuo Kitajima
Jan 9, 2013·Expert Opinion on Therapeutic Targets·Hiroshi KogaTakashi Hashimoto
May 3, 2015·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·R McMillanD Sirois
Feb 7, 2015·Drugs·Cathy Y Zhao, Dedee F Murrell
Oct 4, 2016·American Journal of Clinical Dermatology·AnneLiese SmylieAlain Brassard
Aug 28, 2015·Anais Brasileiros De Dermatologia·Maria Victória QuaresmaLuna Azulay-Abulafia
Dec 18, 2016·Journal of the American Academy of Dermatology·Avrom CaplanRobert G Micheletti
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Linda K MartinDedee F Murrell
Jun 5, 2018·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Claudio FelicianiUNKNOWN "Cutaneous Immunology" group of SIDeMaST
Feb 22, 2012·Annals of Dermatology·Young-Min SonJong-Rok Lee
Dec 2, 2017·The British Journal of Dermatology·K E HarmanP D Yesudian
Jan 8, 2020·International Journal of Dermatology·Nohra GhaouiMazen Kurban
Aug 25, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·P JolyE Schmidt
Mar 20, 2019·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·N van BeekE Schmidt
Jul 12, 2019·Frontiers in Immunology·Dario DidonaMichael Hertl
Oct 27, 2011·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Andrea Kneisel, Michael Hertl
May 12, 2017·Nature Reviews. Disease Primers·Michael KasperkiewiczMasayuki Amagai
Mar 9, 2021·Journal of the American Academy of Dermatology·Carmen M MontagnonStanislav N Tolkachjov
Aug 6, 2021·Veterinary Dermatology·Faith A P Zeng, Dedee F Murrell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.